Impedimetric Detection Based on Label-Free Immunoassay Developed for Targeting Spike S1 Protein of SARS-CoV-2

After the COVID-19 pandemic started all over the world, great importance was placed on the development of sensitive and selective bioanalytical assays for the rapid detection of the highly pathogenic SARS-CoV-2 virus causing COVID-19 disease. In this present work, an impedimetric immunosensor was de...

Descripción completa

Detalles Bibliográficos
Autores principales: Erdem, Arzum, Senturk, Huseyin, Yildiz, Esma, Maral, Meltem
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9407092/
https://www.ncbi.nlm.nih.gov/pubmed/36010342
http://dx.doi.org/10.3390/diagnostics12081992

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9407092/
https://www.ncbi.nlm.nih.gov/pubmed/36010342
http://dx.doi.org/10.3390/diagnostics12081992

Ejemplares similares